Cargando…

Expression of serum miR-27b and miR-451 in patients with congenital heart disease associated pulmonary artery hypertension and risk factor analysis

This study investigated expression of serum miR-27b and miR-451 in patients with congenital heart disease associated pulmonary arterial hypertension (CHD-PAH), and analyzed the risk factors of CHD-PAH. A total of 114 patients with CHD admitted to the First Affiliated Hospital of the University of So...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Leiwang, Xiao, Yunbin, Yin, Xiaocheng, Gao, Shunli, Zhou, Lingzhi, Liu, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444363/
https://www.ncbi.nlm.nih.gov/pubmed/32855688
http://dx.doi.org/10.3892/etm.2020.9042
_version_ 1783573792050642944
author Long, Leiwang
Xiao, Yunbin
Yin, Xiaocheng
Gao, Shunli
Zhou, Lingzhi
Liu, Hui
author_facet Long, Leiwang
Xiao, Yunbin
Yin, Xiaocheng
Gao, Shunli
Zhou, Lingzhi
Liu, Hui
author_sort Long, Leiwang
collection PubMed
description This study investigated expression of serum miR-27b and miR-451 in patients with congenital heart disease associated pulmonary arterial hypertension (CHD-PAH), and analyzed the risk factors of CHD-PAH. A total of 114 patients with CHD admitted to the First Affiliated Hospital of the University of South China were recruited and allocated into a study group (61 patients with PAH) and a control group (53 patients without PAH). Reverse transcription-polymerase chain reaction (RT-PCR) was employed for the qualification of serum miR-27b and miR-451, and an automatic biochemical analyzer was used for the measurement of biochemical indexes in peripheral blood, and enzyme-linked immunosorbent assay (ELISA) for the detection of serum brain natriuretic peptide (BNP) and asymmetric dimethylarginine (ADMA). The patients with CHD-PAH showed higher serum miR-27b, BNP and ADMA but lower miR-451 than the controls. Serum miR-27b was positively correlated with mean pulmonary artery pressure (mPAP), BNP and ADMA, whereas serum miR-451 was negatively correlated with them. The combined detection of miR-27b and miR-451 was more valuable than a single detection in the diagnosis of CHD-PAH. Logistic regression analysis showed that ADMA, miR-27b, miR-451 and ventricular septal defect (VSD) were independent risk factors for CHD-PAH. In conclusion, miR-27b is highly expressed and miR-451 and the expression is low in patients with CHD-PAH. miR-27b and miR-451 are significantly correlated with BNP, ADMA, and the severity of the disease. The combination of miR-27b and miR-451 has high diagnostic value and can be used as a biomarker for the diagnosis and assessment of CHD-PAH. CHD-PAH is common in children with CHD, which poses a serious threat to the life and safety. At present, there are no effective methods for its early diagnosis and treatment. MicroRNAs (miRNAs, miRs) have been found to be closely related to the pathogenesis of CHD-PAH. In this study, miR-27b and miR-451 with differential expression in CHD-PAH were evaluated, and it was found that they were of great significance in the diagnosis and assessment of CHD-PAH.
format Online
Article
Text
id pubmed-7444363
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-74443632020-08-26 Expression of serum miR-27b and miR-451 in patients with congenital heart disease associated pulmonary artery hypertension and risk factor analysis Long, Leiwang Xiao, Yunbin Yin, Xiaocheng Gao, Shunli Zhou, Lingzhi Liu, Hui Exp Ther Med Articles This study investigated expression of serum miR-27b and miR-451 in patients with congenital heart disease associated pulmonary arterial hypertension (CHD-PAH), and analyzed the risk factors of CHD-PAH. A total of 114 patients with CHD admitted to the First Affiliated Hospital of the University of South China were recruited and allocated into a study group (61 patients with PAH) and a control group (53 patients without PAH). Reverse transcription-polymerase chain reaction (RT-PCR) was employed for the qualification of serum miR-27b and miR-451, and an automatic biochemical analyzer was used for the measurement of biochemical indexes in peripheral blood, and enzyme-linked immunosorbent assay (ELISA) for the detection of serum brain natriuretic peptide (BNP) and asymmetric dimethylarginine (ADMA). The patients with CHD-PAH showed higher serum miR-27b, BNP and ADMA but lower miR-451 than the controls. Serum miR-27b was positively correlated with mean pulmonary artery pressure (mPAP), BNP and ADMA, whereas serum miR-451 was negatively correlated with them. The combined detection of miR-27b and miR-451 was more valuable than a single detection in the diagnosis of CHD-PAH. Logistic regression analysis showed that ADMA, miR-27b, miR-451 and ventricular septal defect (VSD) were independent risk factors for CHD-PAH. In conclusion, miR-27b is highly expressed and miR-451 and the expression is low in patients with CHD-PAH. miR-27b and miR-451 are significantly correlated with BNP, ADMA, and the severity of the disease. The combination of miR-27b and miR-451 has high diagnostic value and can be used as a biomarker for the diagnosis and assessment of CHD-PAH. CHD-PAH is common in children with CHD, which poses a serious threat to the life and safety. At present, there are no effective methods for its early diagnosis and treatment. MicroRNAs (miRNAs, miRs) have been found to be closely related to the pathogenesis of CHD-PAH. In this study, miR-27b and miR-451 with differential expression in CHD-PAH were evaluated, and it was found that they were of great significance in the diagnosis and assessment of CHD-PAH. D.A. Spandidos 2020-10 2020-07-24 /pmc/articles/PMC7444363/ /pubmed/32855688 http://dx.doi.org/10.3892/etm.2020.9042 Text en Copyright: © Long et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Long, Leiwang
Xiao, Yunbin
Yin, Xiaocheng
Gao, Shunli
Zhou, Lingzhi
Liu, Hui
Expression of serum miR-27b and miR-451 in patients with congenital heart disease associated pulmonary artery hypertension and risk factor analysis
title Expression of serum miR-27b and miR-451 in patients with congenital heart disease associated pulmonary artery hypertension and risk factor analysis
title_full Expression of serum miR-27b and miR-451 in patients with congenital heart disease associated pulmonary artery hypertension and risk factor analysis
title_fullStr Expression of serum miR-27b and miR-451 in patients with congenital heart disease associated pulmonary artery hypertension and risk factor analysis
title_full_unstemmed Expression of serum miR-27b and miR-451 in patients with congenital heart disease associated pulmonary artery hypertension and risk factor analysis
title_short Expression of serum miR-27b and miR-451 in patients with congenital heart disease associated pulmonary artery hypertension and risk factor analysis
title_sort expression of serum mir-27b and mir-451 in patients with congenital heart disease associated pulmonary artery hypertension and risk factor analysis
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444363/
https://www.ncbi.nlm.nih.gov/pubmed/32855688
http://dx.doi.org/10.3892/etm.2020.9042
work_keys_str_mv AT longleiwang expressionofserummir27bandmir451inpatientswithcongenitalheartdiseaseassociatedpulmonaryarteryhypertensionandriskfactoranalysis
AT xiaoyunbin expressionofserummir27bandmir451inpatientswithcongenitalheartdiseaseassociatedpulmonaryarteryhypertensionandriskfactoranalysis
AT yinxiaocheng expressionofserummir27bandmir451inpatientswithcongenitalheartdiseaseassociatedpulmonaryarteryhypertensionandriskfactoranalysis
AT gaoshunli expressionofserummir27bandmir451inpatientswithcongenitalheartdiseaseassociatedpulmonaryarteryhypertensionandriskfactoranalysis
AT zhoulingzhi expressionofserummir27bandmir451inpatientswithcongenitalheartdiseaseassociatedpulmonaryarteryhypertensionandriskfactoranalysis
AT liuhui expressionofserummir27bandmir451inpatientswithcongenitalheartdiseaseassociatedpulmonaryarteryhypertensionandriskfactoranalysis